Kelly Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17
Closed -$1.15K 329
2024
Q2
$1.15K Hold
17
﹤0.01% 643
2024
Q1
$1.21K Buy
17
+1
+6% +$77 ﹤0.01% 656
2023
Q4
$1.32K Hold
16
﹤0.01% 627
2023
Q3
$1.21K Hold
16
﹤0.01% 602
2023
Q2
$1.24K Sell
16
-27
-63% -$2.15K ﹤0.01% 587
2023
Q1
$3.56K Buy
43
+27
+169% +$2.24K ﹤0.01% 471
2022
Q4
$1.35K Hold
16
﹤0.01% 537
2022
Q3
$962 Buy
16
+1
+7% +$63 ﹤0.01% 573
2022
Q2
$953 Hold
15
﹤0.01% 562
2022
Q1
$906 Hold
15
﹤0.01% 576
2021
Q4
$1.09K Hold
15
﹤0.01% 583
2021
Q3
$1.04K Sell
15
-1,150
-99% -$80.8K ﹤0.01% 567
2021
Q2
$17K Buy
1,165
+1,148
+6,753% +$76.7K ﹤0.01% 560
2021
Q1
$1.08K Sell
17
-154
-90% -$9.93K ﹤0.01% 547
2020
Q4
$9.94K Buy
171
+1
+0.6% +$60 0.01% 273
2020
Q3
$10.8K Sell
170
-10
-6% -$693 0.01% 246
2020
Q2
$13.9K Buy
180
+18
+11% +$1.38K 0.01% 198
2020
Q1
$12.1K Buy
162
+160
+8,000% +$11.1K 0.01% 189
2019
Q4
$131 Buy
+2
New +$130 ﹤0.01% 540

Other funds holding GILD

Kelly Financial Services's GILD Position: Q3 2024 in Review

Kelly Financial Services sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 17 shares — an estimated $1.15K sold.

Kelly Financial Services first reported a position in GILD in Q4 2019 and held it in 19 quarters. The position peaked at $17K in Q2 2021. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Kelly Financial Services reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 17 Gilead Sciences shares in Q3 2024, an estimated $1.15K.
  • Kelly Financial Services first reported a position in Gilead Sciences in Q4 2019 and held it in 19 quarters.
  • Kelly Financial Services's Gilead Sciences position peaked at $17K in Q2 2021.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.